Catalyst Pharmaceuticals Announces Second Quarter 2016 Financial Results and Provides Product Development Update

Go back to Catalyst Pharmaceuticals Announces Second Quarter 2016 Financial Results and Provides Product Development Update

Catyalyst Pharma (CPRX) Tops Q2 EPS by 2c

August 9, 2016 4:29 PM EDT

Catyalyst Pharma (NASDAQ: CPRX) reported Q2 EPS of ($0.06), $0.02 better than the analyst estimate of ($0.08).

For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.

... More